Mantefardo Bahru, Gube Addisu Alemayehu, Awlachew Ephrem, Sisay Gizaw
Department of Internal Medicine, School of Medicine, College of Health and Medicinal Sciences, Dilla University, Dilla, Ethiopia.
Department of Public Health, College of Health and Medicinal Sciences, Dilla University, Dilla, Ethiopia.
Int Med Case Rep J. 2021 Apr 20;14:251-253. doi: 10.2147/IMCRJ.S305693. eCollection 2021.
Though the novel corona virus (COVID-19) mostly affects the respiratory system, it can also result in several neurological complications. One of these is Guillain-Barré Syndrome (GBS) and which is rare and only reported from some parts of the world during this pandemic. Guillain-Barré syndrome (GBS) is an immune-mediated polyradiculoneuropathy. Patients can present with limb or cranial-nerves weakness, loss of deep tendon reflexes, sensory and dysautonomic symptoms. The main pathophysiology for the clinical presentation is demyelination and/or axonal damage to peripheral nerves or roots. Neurological manifestations are more commonly associated with severe COVID-19 infection. Here, we present a case of Guillain-Barré syndrome associated with COVID-19 in Ethiopia.
尽管新型冠状病毒(COVID-19)主要影响呼吸系统,但它也可能导致多种神经系统并发症。其中之一是吉兰-巴雷综合征(GBS),这种情况较为罕见,在此次大流行期间仅在世界某些地区有报道。吉兰-巴雷综合征(GBS)是一种免疫介导的多发性神经根神经病。患者可能出现肢体或颅神经无力、深部腱反射消失、感觉和自主神经功能障碍症状。临床表现的主要病理生理学是周围神经或神经根的脱髓鞘和/或轴索损伤。神经系统表现更常与重症COVID-19感染相关。在此,我们报告一例在埃塞俄比亚发生的与COVID-19相关的吉兰-巴雷综合征病例。